Cas:900174-65-4 3-Ethoxy-4-fluorophenylboronic acid manufacturer & supplier

We serve Chemical Name:3-Ethoxy-4-fluorophenylboronic acid CAS:900174-65-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Ethoxy-4-fluorophenylboronic acid

Chemical Name:3-Ethoxy-4-fluorophenylboronic acid
CAS.NO:900174-65-4
Synonyms:(3-ethoxy-4-fluorophenyl)boronic acid
Molecular Formula:C8H10BFO3
Molecular Weight:183.97300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.69000
Exact Mass:184.07100
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (3-ethoxy-4-fluorophenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3-ethoxy-4-fluorophenyl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-ethoxy-4-fluorophenyl)boronic acid Use and application,(3-ethoxy-4-fluorophenyl)boronic acid technical grade,usp/ep/jp grade.


Related News: Russia, which shares a 2,600-mile border with China, reported its first two coronavirus cases on Friday. 3-Ethoxy-4-fluorophenylboronic acid manufacturer The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. 3-Ethoxy-4-fluorophenylboronic acid supplier The GLOW trial doesn’t yet have the answer to that question, but Tendler pointed to encouraging early evidence from the regimen’s phase 2 trial, dubbed CAPTIVATE. Among eight patients who progressed after stopping the fixed-duration combo, six responded to subsequent Imbruvica monotherapy, while the other two didn’t have a response report, according to data presented at the recent American Society of Clinical Oncology annual meeting. 3-Ethoxy-4-fluorophenylboronic acid vendor f you’ve traveled in or transited through mainland China, you won’t be allowed into New Zealand unless you’re a New Zealand national. 3-Ethoxy-4-fluorophenylboronic acid factory Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s.